Sensor-Guided CPAP Therapy Adaptation for Pulmonary Hyperinflation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing CPAP therapies cause pulmonary hyperinflation, leading to adverse consequences such as increased thoracic pressure, sympathetic outflow, heart rate variability, and cardiac arrhythmias, particularly in patients with comorbidities like COPD and OSA, necessitating a system to detect and mitigate hyperinflation for improved therapy efficacy and compliance.
Innovation Solution
A CPAP system with hyperinflation sensing and a controller that adjusts therapy settings based on sensor data from ECG, PPG, and flow sensors to detect hyperinflation, reducing therapeutic air assist and pressure support when critical hyperinflation is detected, and returning to initial settings when conditions improve.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If positive airway pressure is increased to treat sleep apnea, then apnea hypopnea index improvement is achieved, but pulmonary hyperinflation occurs causing adverse cardiac effects
Solution Approach 1:
The system continuously monitors expiratory flow patterns, rise time of expiration, and cardiac parameters (ECG, PPG) to detect hyperinflation in real-time. When hyperinflation is detected, the controller automatically adjusts pressure settings to reduce it, creating a closed-loop feedback system that balances apnea treatment with hyperinflation mitigation.
Solution Approach 2:
The system dynamically adjusts pressure support and therapeutic air assist based on detected breathing patterns and hyperinflation status. Pressure settings are not static but adapt in real-time to patient needs, reducing pressure when hyperinflation occurs and restoring it when conditions improve.
2Ease of operation
If PAP pressure settings are increased from 4 through 8 cmH2O, then breathing effort switches from passive to active expiration, but muscular breathing effort increases causing hyperinflation in deep sleep
Solution Approach 1:
The system monitors expiratory flow patterns and rise time to detect when active expiration leads to hyperinflation. When hyperinflation is detected during sleep, the controller reduces pressure support to allow passive expiration, preventing the harmful accumulation of lung volume while maintaining adequate airway patency.
Solution Approach 2:
The system changes pressure parameters dynamically based on sleep stage and breathing pattern detection. Pressure support is adjusted according to the patient's muscular effort capability, which varies with sleep depth, thereby preventing hyperinflation during deep sleep while maintaining effective breathing support during lighter sleep stages.
3Productivity
If hyperinflation is uncontrolled, then therapy pressure support continues, but adverse consequences include increased thoracic pressure, sympathetic outflow, and cardiac arrhythmias
Solution Approach 1:
The system uses multiple sensors (ECG, PPG, flow sensors) to continuously monitor cardiac function and detect arrhythmias caused by hyperinflation. When arrhythmias or critical hyperinflation is detected, the controller immediately reduces pressure support to eliminate the harmful effect while maintaining adequate respiratory support.
Solution Approach 2:
The system introduces an intermediary detection and control layer between the pressure support delivery and the patient's respiratory system. Sensors detect intermediate parameters (expiratory flow rise time, cardiac output variability) that indicate impending hyperinflation before it causes severe cardiac effects, allowing preventive pressure adjustment.
4Reliability
If multiple sensors and adaptive control are added to detect and mitigate hyperinflation, then therapy safety improves, but device complexity increases
Solution Approach 1:
The system uses multi-functional sensors that serve multiple purposes: flow sensors detect both breathing patterns and hyperinflation; ECG and PPG sensors monitor both cardiac rhythm and stroke volume variability as indicators of hyperinflation. This multi-functionality reduces the need for separate dedicated sensors for each measurement.
Solution Approach 2:
The system combines multiple detection functions into a unified control algorithm that processes expiratory flow patterns, rise time measurements, and cardiac parameters together to detect hyperinflation. The controller integrates these multiple data streams into a single adaptive pressure control system, managing complexity through unified processing rather than separate control loops.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system effectively mitigates pulmonary hyperinflation, improving sleep quality and cardiac function, reducing arousals, and enhancing therapy compliance by personalizing pressure adaptation for individual patient needs.
Implementation Method 1
a flow sensor configured to detect expiratory flow patterns
Implementation Method 2
at least one photoplethysmogram (PPG) sensor configured to measure variability in stroke volume (SV), ejection fraction (EF), and/or cardiac output (CO)
Implementation Method 3
at least one electrocardiogram (ECG) sensor
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A positive airway pressure therapy device, which may include one or more of at least one controller; a flow generator configured to provide therapeutic air assist; a plurality of sensors including at least one electrocardiogram (ECG) sensor, and at least one photoplethysmogram (PPG) sensor, the at least one PPG sensor may be configured to determine hyperinflation and the implication on variability in stroke volume and ejection fraction and form corresponding stroke volume (SV) and ejection fraction (EF) information, and the at least one ECG sensor configured to sense heart rate (HR) and heart rate variability (HRV) and form corresponding HR and HRV sensor information; the at least one controller may be configured to: control a flow generator to provide the therapeutic air assist to the user in accordance with initial pressure values determined in accordance with default setting values; and may determine whether a venous return flow (VRF) is less than a venous threshold.